Endovia Health Sciences, Inc. (EDVA) Gross margin 2016–2025
Endovia Health Sciences, Inc. (EDVA) gross margin by fiscal year — reported gross profit divided by reported revenue.
23.1%FY2025 · since FY2016: 52.1% → 23.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 23.1% | +38.1 pp |
| FY2024 | -15.0% | -44.5 pp |
| FY2023 | 29.5% | -3.2 pp |
| FY2022 | 32.7% | -1.9 pp |
| FY2021 | 34.6% | +18.8 pp |
| FY2020 | 15.8% | +1120.0 pp |
| FY2019 | -1104.2% | -1158.0 pp |
| FY2018 | 53.8% | +3.0 pp |
| FY2017 | 50.8% | -1.3 pp |
| FY2016 | 52.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More EDVA financial trends
EDVA RevenueEDVA Net incomeEDVA Net marginEDVA Gross profitEDVA Operating incomeEDVA Operating marginEDVA Operating cash flowEDVA Free cash flowEDVA Capital expendituresEDVA Return on equityEDVA Stock buybacksEDVA Dividends paidEDVA Total assetsEDVA Total liabilitiesEDVA Shareholders’ equityEDVA overview →